Maria Grammoustianou

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Venous Thromboembolism

Decision Making

Positive Breast Cancer

Monoclonal Antibody

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Maria Grammoustianou, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras
Current Status and Future Perspectives of Antibody-Drug Conjugates in Hormone Receptor-Positive Breast Cancer. Cancers 16 (10) (2024)
Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Maria Grammoustianou, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras
Current Status and Future Perspectives of Antibody-Drug Conjugates in Hormone Receptor-Positive Breast Cancer. Cancers 16 (10) (2024)
Marousa Kouvela, Maria Effrosyni Livanou, Dimitra T Stefanou, Ioannis A Vathiotis, Fotini Sarropoulou, Maria Grammoustianou, Evangelos Dimakakos, Nikolaos K Syrigos
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers 16 (7) (2024)
Ioannis P Trontzas, Ioannis A Vathiotis, Christina Economidou, Ioulia Petridou, Georgia Gomatou, Maria Grammoustianou, Ioannis Tsamis, Nikolaos Syrigos, Maximilian Anagnostakis, Eleni Fyta, Vissaria Sakka, Garyphalia Poulakou, Elias A Kotteas, Ekaterini Syrigou
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer. Vaccines 10 (4) (2022)